Skip to main content
Erschienen in: International Cancer Conference Journal 1/2016

01.01.2016 | Case report

The short term feasibility of abdominoperineal resection with prostatectomy for locally advanced rectal cancer: open and laparoscopic cases report

verfasst von: Ryota Nakanishi, Ikuo Takahashi, Yuichiro Kajiwara, Takashi Motomura, Yoshihiko Fujinaka, Shin-ichiro Maehara, Takuya Honboh, Yuji Soejima, Takashi Nishizaki, Akira Yano, Takatoshi Tacho

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Total pelvic exenteration is often selected for advanced rectal cancer with prostatic invasion. The aim of this study was to evaluate the short term feasibility of the abdominoperineal resection with prostatectomy for locally advanced rectal cancer. We performed abdominoperineal resection with prostatectomy for 3 patients with locally advanced rectal cancer, including 2 patients by totally laparoscopic procedure. Patients’ background, intra- and postoperative factors and short-term prognosis were evaluated. All patients underwent complete resection of primary tumor with negative surgical margins. We could perform the surgery by both open and laparoscopic procedure in collaboration with urologist. There was no operation related mortality. One patient who was treated by open procedure had urinary anastomotic leakage. No patient had recurrenced, but one patient died of other disease. Our experience suggests that open or laparoscopic abdominoperineal resection with prostatectomy could be an alternative to total pelvic exenteration for the patients with rectal cancer invading the prostate. The collaboration with the urologist would be important to perform quality-controlled surgery.
Literatur
2.
3.
Zurück zum Zitat Yang TX, Morris DL, Chua TC (2013) Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 56:519–531CrossRefPubMed Yang TX, Morris DL, Chua TC (2013) Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 56:519–531CrossRefPubMed
4.
Zurück zum Zitat Wiig JN, Waehre H, Larsen SG et al (2003) Radical prostatectomy for locally advanced primary or recurrent rectal cancer. Eur J Surg Oncol 29:455–458CrossRefPubMed Wiig JN, Waehre H, Larsen SG et al (2003) Radical prostatectomy for locally advanced primary or recurrent rectal cancer. Eur J Surg Oncol 29:455–458CrossRefPubMed
5.
Zurück zum Zitat Saito N, Suzuki T, Sugito M et al (2007) Bladder-sparing extended resection of locally advanced rectal cancer involving the prostate and seminal vesicles. Surg Today 37:845–852CrossRefPubMed Saito N, Suzuki T, Sugito M et al (2007) Bladder-sparing extended resection of locally advanced rectal cancer involving the prostate and seminal vesicles. Surg Today 37:845–852CrossRefPubMed
6.
Zurück zum Zitat Ahmad NZ, Racheva G, Elmusharaf H (2013) Systematic review and meta-analysis of randomized and non-randomized studies comparing laparoscopic and open abdominoperineal resection for rectal cancer. Colorectal Dis 15:269–277CrossRefPubMed Ahmad NZ, Racheva G, Elmusharaf H (2013) Systematic review and meta-analysis of randomized and non-randomized studies comparing laparoscopic and open abdominoperineal resection for rectal cancer. Colorectal Dis 15:269–277CrossRefPubMed
7.
Zurück zum Zitat Tooher R, Swindle P, Woo H et al (2006) Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studies. J Urol 6:2011–2017CrossRef Tooher R, Swindle P, Woo H et al (2006) Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studies. J Urol 6:2011–2017CrossRef
8.
Zurück zum Zitat Nakanishi R, Takahashi I, Fujinaka Y et al (2014) Laparoscopic abdominoperineal resection combined with prostatectomy for rectal cancer invading the prostate: a case report (in Japanese). Nihon Naishikyo Gekagakkaizassi (J Jpn Soc Endosc Surg) 19:199–204 Nakanishi R, Takahashi I, Fujinaka Y et al (2014) Laparoscopic abdominoperineal resection combined with prostatectomy for rectal cancer invading the prostate: a case report (in Japanese). Nihon Naishikyo Gekagakkaizassi (J Jpn Soc Endosc Surg) 19:199–204
9.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y et al (2007) Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 245:80–87PubMedCentralCrossRefPubMed Ueno H, Mochizuki H, Hashiguchi Y et al (2007) Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 245:80–87PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Akasu T, Moriya Y, Ohashi Y et al (2006) Adjuvant chemotherapy with uracil tegafur for pathological stageIII rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36:237–244CrossRefPubMed Akasu T, Moriya Y, Ohashi Y et al (2006) Adjuvant chemotherapy with uracil tegafur for pathological stageIII rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36:237–244CrossRefPubMed
11.
Zurück zum Zitat Engstrom PF, Arnoletti JP, Benson AB 3rd et al (2009) NCCN clinical practice guidelines in oncology: rectal cancer. J Natl Compr Canc Netw 7:838–881PubMed Engstrom PF, Arnoletti JP, Benson AB 3rd et al (2009) NCCN clinical practice guidelines in oncology: rectal cancer. J Natl Compr Canc Netw 7:838–881PubMed
12.
Zurück zum Zitat Tural D, Selcukbiricik F, Yıldız O et al (2014) Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. Int J Clin Oncol 19:889–896CrossRefPubMed Tural D, Selcukbiricik F, Yıldız O et al (2014) Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. Int J Clin Oncol 19:889–896CrossRefPubMed
13.
Zurück zum Zitat van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicenter, randomised controlled TME trial. Lancet Oncol 12:575–582CrossRefPubMed van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicenter, randomised controlled TME trial. Lancet Oncol 12:575–582CrossRefPubMed
14.
Zurück zum Zitat Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999CrossRefPubMed Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999CrossRefPubMed
15.
Zurück zum Zitat Hwang MR, Park JW, Park S, Yoon H, Kim DY et al (2014) Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol 21:1345–1351CrossRefPubMed Hwang MR, Park JW, Park S, Yoon H, Kim DY et al (2014) Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol 21:1345–1351CrossRefPubMed
16.
Zurück zum Zitat Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711CrossRefPubMed Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711CrossRefPubMed
17.
Zurück zum Zitat Tilney HS, Rasheed S, Northover JM et al (2009) The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery. Dis Colon Rectum 52:1723–1729CrossRefPubMed Tilney HS, Rasheed S, Northover JM et al (2009) The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery. Dis Colon Rectum 52:1723–1729CrossRefPubMed
18.
Zurück zum Zitat Caras RJ, Lustik MB, Kern SQ et al (2014) Laparoscopic radical prostatectomy demonstrates less morbidity than open radical prostatectomy: an analysis of the American College of Surgeons-National Surgical Quality Improvement Program database with a focus on surgical trainee involvement. J Endourol 28:298–305CrossRefPubMed Caras RJ, Lustik MB, Kern SQ et al (2014) Laparoscopic radical prostatectomy demonstrates less morbidity than open radical prostatectomy: an analysis of the American College of Surgeons-National Surgical Quality Improvement Program database with a focus on surgical trainee involvement. J Endourol 28:298–305CrossRefPubMed
19.
Zurück zum Zitat Simone G, Papalia R, Ferriero M et al (2012) Laparoscopic “single knot-single running” suture vesico-urethral anastomosis with posterior musculofascial reconstruction. World J Urol 30:651–657CrossRefPubMed Simone G, Papalia R, Ferriero M et al (2012) Laparoscopic “single knot-single running” suture vesico-urethral anastomosis with posterior musculofascial reconstruction. World J Urol 30:651–657CrossRefPubMed
Metadaten
Titel
The short term feasibility of abdominoperineal resection with prostatectomy for locally advanced rectal cancer: open and laparoscopic cases report
verfasst von
Ryota Nakanishi
Ikuo Takahashi
Yuichiro Kajiwara
Takashi Motomura
Yoshihiko Fujinaka
Shin-ichiro Maehara
Takuya Honboh
Yuji Soejima
Takashi Nishizaki
Akira Yano
Takatoshi Tacho
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 1/2016
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-015-0218-6

Weitere Artikel der Ausgabe 1/2016

International Cancer Conference Journal 1/2016 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.